Risks associated with systemic exposure to estradiol creams

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Active substance
estradiol
Procedure number
EMEA/H/A-31/1482
Regulatory outcome
Variation
DHPC type
Referral - Article 31
Referral name
Estradiol-containing (0.01% w/w) medicinal products for topical use
Human ATC code
G03CA03
Dissemination date
20/02/2020
Related medicines

How useful was this page?

Add your rating
Average